Global Retinal Vein Occlusion Market 2014-2018

世界の網膜静脈閉塞症治療市場(2014-2018)

◆タイトル:Global Retinal Vein Occlusion Market 2014-2018
◆商品コード:IRTNTR3864
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年7月23日
◆ページ数:77
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の網膜静脈閉塞症治療市場(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、種類別分析、投与経路(ROA)別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Retinal Vein Occlusion
Retinal vein occlusion is a medical condition where there is a blockage in the retinal veins. This blocks the flow of blood in the retina, which can damage the nerve cells of the eye and result in loss of vision. Retinal vein occlusion can occur as a result of a clot in a vein, especially if the veins of the eye are very narrow. The disease is likely to affect people who are already suffering from hypertension, diabetes mellitus, or hyperlipidaemia. Retinal vein occlusion is one of the most common causes of blindness after diabetic retinopathy. It is also one of the most common vascular disorders of the eye. Retinal vein occlusion can be broadly classified into two types, central retinal vein occlusion and branch retinal vein occlusion, with the latter being more frequent. Central retinal vein occlusion can be divided into two further subtypes, ischemic central retinal vein occlusion and non-ischemic central retinal vein occlusion.

TechNavio’s analysts forecast the Global Retinal Vein Occlusion market will grow at a CAGR of 16.04 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Retinal Vein Occlusion market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of retinal vein occlusion.
TechNavio’s report, the Global Retinal Vein Occlusion Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Retinal Vein Occlusion market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
Other Prominent Vendors

• Alimera Sciences
• Bristol-Myers Squibb
• NicOx
• Santen Pharmaceutical Co.
• Valeant Pharmaceuticals International
Key Market Driver
• High Unmet Need
• For a full, detailed list, view our report.
Key Market Challenge
• Serious Adverse Side Effects
• For a full, detailed list, view our report.
Key Market Trend
• Introduction of Biologics
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
Product Portfolio
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Pipeline Portfolio
08. Rate of Incidence and Prevalence
09. Market Segmentation by Type of Therapy
09.1.1 Biologics
09.1.2 Corticosteroids
10. Market Segmentation by Route of Administration
10.1.1 Intravitreal
10.1.2 Intravenous
11. Market Segmentation by Dosage Forms
11.1.1 Solutions
11.1.2 Implant
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.2.1 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Bayer
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Business Segmentation by Revenue 2012 and 2013
21.1.5 Sales by Geography
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.1.9 Strengths
21.1.10 Weaknesses
21.1.11 Opportunities
21.1.12 Threats
21.2 Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.2.9 Strengths
21.2.10 Weaknesses
21.2.11 Opportunities
21.2.12 Threats
21.3 Novartis
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Business Strategy
21.3.7 Key Developments
21.3.8 SWOT Analysis
21.3.9 Strengths
21.3.10 Weaknesses
21.3.11 Opportunities
21.3.12 Threats
21.4 Regeneron Pharmaceuticals
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Revenue Product Segmentation
21.4.5 Business Strategy
21.4.6 Key Information
21.4.7 SWOT Analysis
21.4.8 Strengths
21.4.9 Weaknesses
21.4.10 Opportunities
21.4.11 Threats
22. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Retinal Vein Occlusion Market 2013-2018 (US$ million)
Exhibit 3: Pipeline Portfolio of the Drugs for the Treatment of Retinal Vein Occlusion
Exhibit 4: Global Retinal Vein Occlusion Market by Type of Therapy
Exhibit 5: Global Retinal Vein Occlusion Market by Route of Administration
Exhibit 6: Global Retinal Vein Occlusion Market by Dosage Forms
Exhibit 7: Global Retinal Vein Occlusion Market by Geographical Segmentation
Exhibit 8: Global Retinal Vein Occlusion Market Share Analysis 2013
Exhibit 9: Product-wise Revenue Share in Global Retinal Vein Occlusion Market 2013
Exhibit 10: Bayer AG: Business Segmentation 2013
Exhibit 11: Bayer AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 12: Bayer AG: Sales by Geography 2013
Exhibit 13: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 14: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
Exhibit 15: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 16: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
Exhibit 17: Novartis AG: Business Segmentation by Revenue 2013
Exhibit 18: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 19: Novartis AG: Sales by Geography 2013
Exhibit 20: Regeneron Pharmaceuticals Inc.: Product Segmentation
Exhibit 21: Regeneron Pharmaceuticals Inc.: Revenue Product Segmentation 2013



【掲載企業】

Bayer AG,F. Hoffmann-La Roche Ltd.,Novartis AG,Regeneron Pharmaceuticals Inc.,Alimera Sciences,Bristol-Myers Squibb,NicOx,Santen Pharmaceutical Co.,Valeant Pharmaceuticals International

【資料のキーワード】

網膜静脈閉塞症、網膜静脈、治療、薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の網膜静脈閉塞症治療市場(2014-2018)] (Global Retinal Vein Occlusion Market 2014-2018 / IRTNTR3864)販売に関する免責事項
[世界の網膜静脈閉塞症治療市場(2014-2018)] (Global Retinal Vein Occlusion Market 2014-2018 / IRTNTR3864)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆